The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
The global Rifampicin market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 193 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Rifampicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rifampicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rifampicin include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, Mercator Pharmaceutical Solutions and ASIAN PHARMACY, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rifampicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifampicin.
Report Scope
The Rifampicin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifampicin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifampicin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Segment by Type
Oral
Intravenous Injection
Segment by Application
Tuberculosis
Leprosy
Legionnaire's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rifampicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rifampicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
The global Rifampicin market was valued at US$ 124 million in 2023 and is anticipated to reach US$ 193 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Rifampicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rifampicin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rifampicin include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, Mercator Pharmaceutical Solutions and ASIAN PHARMACY, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rifampicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifampicin.
Report Scope
The Rifampicin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifampicin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifampicin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Segment by Type
Oral
Intravenous Injection
Segment by Application
Tuberculosis
Leprosy
Legionnaire's Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rifampicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rifampicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rifampicin Market Overview
1.1 Product Overview and Scope of Rifampicin
1.2 Rifampicin Segment by Type
1.2.1 Global Rifampicin Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Intravenous Injection
1.3 Rifampicin Segment by Application
1.3.1 Global Rifampicin Market Value by Application: (2024-2030)
1.3.2 Tuberculosis
1.3.3 Leprosy
1.3.4 Legionnaire's Disease
1.3.5 Others
1.4 Global Rifampicin Market Size Estimates and Forecasts
1.4.1 Global Rifampicin Revenue 2019-2030
1.4.2 Global Rifampicin Sales 2019-2030
1.4.3 Global Rifampicin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rifampicin Market Competition by Manufacturers
2.1 Global Rifampicin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rifampicin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rifampicin Average Price by Manufacturers (2019-2024)
2.4 Global Rifampicin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rifampicin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rifampicin, Product Type & Application
2.7 Rifampicin Market Competitive Situation and Trends
2.7.1 Rifampicin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rifampicin Players Market Share by Revenue
2.7.3 Global Rifampicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rifampicin Retrospective Market Scenario by Region
3.1 Global Rifampicin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rifampicin Global Rifampicin Sales by Region: 2019-2030
3.2.1 Global Rifampicin Sales by Region: 2019-2024
3.2.2 Global Rifampicin Sales by Region: 2025-2030
3.3 Global Rifampicin Global Rifampicin Revenue by Region: 2019-2030
3.3.1 Global Rifampicin Revenue by Region: 2019-2024
3.3.2 Global Rifampicin Revenue by Region: 2025-2030
3.4 North America Rifampicin Market Facts & Figures by Country
3.4.1 North America Rifampicin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rifampicin Sales by Country (2019-2030)
3.4.3 North America Rifampicin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rifampicin Market Facts & Figures by Country
3.5.1 Europe Rifampicin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rifampicin Sales by Country (2019-2030)
3.5.3 Europe Rifampicin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rifampicin Market Facts & Figures by Country
3.6.1 Asia Pacific Rifampicin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rifampicin Sales by Country (2019-2030)
3.6.3 Asia Pacific Rifampicin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rifampicin Market Facts & Figures by Country
3.7.1 Latin America Rifampicin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rifampicin Sales by Country (2019-2030)
3.7.3 Latin America Rifampicin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rifampicin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rifampicin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rifampicin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rifampicin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rifampicin Sales by Type (2019-2030)
4.1.1 Global Rifampicin Sales by Type (2019-2024)
4.1.2 Global Rifampicin Sales by Type (2025-2030)
4.1.3 Global Rifampicin Sales Market Share by Type (2019-2030)
4.2 Global Rifampicin Revenue by Type (2019-2030)
4.2.1 Global Rifampicin Revenue by Type (2019-2024)
4.2.2 Global Rifampicin Revenue by Type (2025-2030)
4.2.3 Global Rifampicin Revenue Market Share by Type (2019-2030)
4.3 Global Rifampicin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rifampicin Sales by Application (2019-2030)
5.1.1 Global Rifampicin Sales by Application (2019-2024)
5.1.2 Global Rifampicin Sales by Application (2025-2030)
5.1.3 Global Rifampicin Sales Market Share by Application (2019-2030)
5.2 Global Rifampicin Revenue by Application (2019-2030)
5.2.1 Global Rifampicin Revenue by Application (2019-2024)
5.2.2 Global Rifampicin Revenue by Application (2025-2030)
5.2.3 Global Rifampicin Revenue Market Share by Application (2019-2030)
5.3 Global Rifampicin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Rifampicin Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Wellona Pharma
6.2.1 Wellona Pharma Corporation Information
6.2.2 Wellona Pharma Description and Business Overview
6.2.3 Wellona Pharma Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Wellona Pharma Rifampicin Product Portfolio
6.2.5 Wellona Pharma Recent Developments/Updates
6.3 AVANSCURE LIFESCIENCES
6.3.1 AVANSCURE LIFESCIENCES Corporation Information
6.3.2 AVANSCURE LIFESCIENCES Description and Business Overview
6.3.3 AVANSCURE LIFESCIENCES Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AVANSCURE LIFESCIENCES Rifampicin Product Portfolio
6.3.5 AVANSCURE LIFESCIENCES Recent Developments/Updates
6.4 Hebei Xingang Pharmaceutical
6.4.1 Hebei Xingang Pharmaceutical Corporation Information
6.4.2 Hebei Xingang Pharmaceutical Description and Business Overview
6.4.3 Hebei Xingang Pharmaceutical Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hebei Xingang Pharmaceutical Rifampicin Product Portfolio
6.4.5 Hebei Xingang Pharmaceutical Recent Developments/Updates
6.5 Mercator Pharmaceutical Solutions
6.5.1 Mercator Pharmaceutical Solutions Corporation Information
6.5.2 Mercator Pharmaceutical Solutions Description and Business Overview
6.5.3 Mercator Pharmaceutical Solutions Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mercator Pharmaceutical Solutions Rifampicin Product Portfolio
6.5.5 Mercator Pharmaceutical Solutions Recent Developments/Updates
6.6 ASIAN PHARMACY
6.6.1 ASIAN PHARMACY Corporation Information
6.6.2 ASIAN PHARMACY Description and Business Overview
6.6.3 ASIAN PHARMACY Rifampicin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ASIAN PHARMACY Rifampicin Product Portfolio
6.6.5 ASIAN PHARMACY Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rifampicin Industry Chain Analysis
7.2 Rifampicin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rifampicin Production Mode & Process
7.4 Rifampicin Sales and Marketing
7.4.1 Rifampicin Sales Channels
7.4.2 Rifampicin Distributors
7.5 Rifampicin Customers
8 Rifampicin Market Dynamics
8.1 Rifampicin Industry Trends
8.2 Rifampicin Market Drivers
8.3 Rifampicin Market Challenges
8.4 Rifampicin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
